trending Market Intelligence /marketintelligence/en/news-insights/trending/pCAN0sfZ6OeTUmb_kYSrOA2 content esgSubNav
In This List

Evotec completes £55.7 million Cyprotex acquisition

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Evotec completes £55.7 million Cyprotex acquisition

Evotec AG completed its previously announced acquisition of Cyprotex PLC for £55.7 million in cash, including debt.

The purchase is expected to boost Evotec's revenues by €18 million to €20 million in 2017 while also helping the company's EBITDA for the year.